Neuropsychopharmacology (journal)
| Neuropsychopharmacology | |
|---|---|
 | |
| Abbreviated title (ISO 4) | Neuropsychopharmacology |
| Discipline | Neuropsychopharmacology |
| Language | English |
| Edited by | William A. Carlezon Jr. |
| Publication details | |
| Publisher | Nature Publishing Group |
| Publication history | 1987-present |
| Frequency | Monthly |
| Open access | Delayed, after 12 months |
| Impact factor (2012) | 8.678 |
| Indexing | |
| ISSN |
0893-133X (print) 1740-634X (web) |
| CODEN | NEROEW |
| OCLC number | 815994337 |
| Links | |
Neuropsychopharmacology is a peer-reviewed scientific journal published by the Nature Publishing Group. It has been the official publication of the American College of Neuropsychopharmacology since 1987. The journal covers topics in neuropsychopharmacology, including clinical and basic science research into the brain and behavior, the properties of agents acting within the central nervous system, and drug targeting and development.
Abstracting and indexing
The journal is abstracted and indexed in:[1][2][3]
According to the Journal Citation Reports, the journal has a 2012 impact factor of 8.678.[4]
In addition to monthly issues, the journal also publishes a special 13th issue in January, called Neuropsychopharmacology Reviews, focusing on a special theme. The journal also produces free podcasts to highlight research reports that may be of particular interest to the public; a podcast is also released in January to complement the reviews issue.
References
- ↑ "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2014-02-07.
- ↑ "Neuropsychopharmacology". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-02-07.
- ↑ "Scopus title list" (Microsoft Excel). Elsevier. Retrieved 2014-02-07.
- ↑ "Neuropsychopharmacology". 2012 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2013.